Navigation Links
Gen-Probe to Consolidate Industrial Assets Into New, Independent Company
Date:9/14/2009

Probe

Gen-Probe Incorporated is a global leader in the development, manufacture and marketing of rapid, accurate and cost-effective nucleic acid tests (NATs) that are used primarily to diagnose human diseases and screen donated human blood. Gen-Probe has more than 25 years of NAT expertise, and received the 2004 National Medal of Technology, America's highest honor for technological innovation, for developing NAT assays for blood screening. Gen-Probe is headquartered in San Diego and employs approximately 1,200 people. For more information, go to www.gen-probe.com.

Caution Regarding Forward-Looking Statements

Any statements in this press release about Gen-Probe's expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and are forward-looking statements. These statements are often, but not always, made through the use of words or phrases such as believe, will, expect, anticipate, estimate, intend, plan and would. For example, statements concerning new industrial products, customer adoption of these products, and results of future R&D studies are all forward-looking statements. Forward-looking statements are not guarantees of performance. They involve known and unknown risks, uncertainties and assumptions that may cause actual results, levels of activity, performance or achievements to differ materially from those expressed or implied. Some of the risks, uncertainties and assumptions that could cause actual results to differ materially from estimates or projections contained in the forward-looking statements include but are not limited to: (i) the risk that Roka's development of industrial assays and pl
'/>"/>

SOURCE Gen-Probe Incorporated
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Gen-Probe to Webcast Presentation at Bank of Americas 37th Annual Investment Conference
2. Gen-Probe Reports Strong Financial Results for Third Quarter 2007, Raises Full-Year Guidance for Earnings Per Share and Total Revenues
3. Gen-Probe to Webcast Three Upcoming Presentations
4. Gen-Probe Announces Webcast of Fourth Quarter and Full Year 2007 Earnings Conference Call
5. Carl Hull Named President and Chief Operating Officer of Gen-Probe
6. Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2007
7. Gen-Probe to Webcast Presentations at Lehman and Cowen Healthcare Conferences
8. Gen-Probe to Webcast Presentation at Morgan Stanley Global Healthcare Unplugged Conference
9. Gen-Probe Reports Strong Financial Results for First Quarter 2008, Raises Full-Year Guidance
10. Gen-Probe to Webcast Presentation at Deutsche Bank 33rd Annual Health Care Conference
11. Lucy Shapiro, Ph.D., Elected to Gen-Probe Board of Directors

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)...ov. 19 Spherix Incorpora...y for diabetes therapy, and a provider of technica...lement, biotechnology and pharmaceutical companies...d $6.3 million registered direct placement to inst...mon stock and warrants to purchase up to 1,104,348...
(Date:11/19/2009)...wswire-FirstCall/ -- Spherix Incorporated (Nasdaq:...es therapy, and a provider of technical and regula...echnology and pharmaceutical companies, today anno...hareholders. ,, At the meeting, shareholders of... following members to the Board of Directors: ,...
(Date:11/19/2009)...ember 19 MONITORING FORCE GmbH,ann... Flibanserin in the,indication treatment-relevant ... for orphan drug status designation with the Europ...inesia is a complication of the mainstay,treatment...ome of those,affected, since it may be disabling f...
(Date:11/19/2009)...geons and recognized refractive and cataract surge...rought their fellow surgeons up-to-date on the lat...aract surgery, and ophthalmology in general at the...ogy (AAO) annual meeting in San Francisco, Califor.... David Huang, MD, Dr. Randy Epstein, Dr. William ...
Breaking Biology Technology:Spherix Announces the Closing of $6.3 Million Registered Direct Offering 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 3Spherix Announces Results of Annual Shareholders Meeting 2Spherix Announces Results of Annual Shareholders Meeting 3Spherix Announces Results of Annual Shareholders Meeting 4MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug" 2Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 2Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 3Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 4Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 5Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 6Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 7Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 8Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 9
... 17 Poniard,Pharmaceuticals, Inc. (Nasdaq: PARD ..., today announced that its lead product candidate,...uct designation for the treatment of,small cell lu...designation,is based on a recommendation from the ...the European Medicines Agency (EMEA). Picoplatin ...
...lt announced today that,the Henry C. Witelson Ocul...ealth Centre has purchased a Personal Archive bios... in Montreal, Quebec. GenVault technology will be... in determining the mechanisms underlying eye canc...for developing new approaches for,treatment. These...
...ea Pharmaceuticals,Inc. announced today that BC De...diagnostic test, is now available from Panacea Lab...at should facilitate the identification,of recurre...ncer. Panacea,Laboratories, a division of Panacea ...aboratory Improvement Amendments of 1988 (CLIA). T...
Other Biology Technology:Poniard Pharmaceuticals Announces European Commission Grants Orphan Medicinal Product Designation to Picoplatin for Treatment of Small Cell Lung Cancer 2Poniard Pharmaceuticals Announces European Commission Grants Orphan Medicinal Product Designation to Picoplatin for Treatment of Small Cell Lung Cancer 3Poniard Pharmaceuticals Announces European Commission Grants Orphan Medicinal Product Designation to Picoplatin for Treatment of Small Cell Lung Cancer 4McGill University Purchases GenVault's Personal Archive System to Manage Rare Cancer Samples 2Panacea Pharmaceuticals Announces the Availability of BC Detect(SM), a Serum- Based Diagnostic Test for Breast Cancer 2Panacea Pharmaceuticals Announces the Availability of BC Detect(SM), a Serum- Based Diagnostic Test for Breast Cancer 3Panacea Pharmaceuticals Announces the Availability of BC Detect(SM), a Serum- Based Diagnostic Test for Breast Cancer 4
(Date:11/23/2009)... The National Institute of General Medical Science...th (NIH), is investing $42.3 million for grants in...ities (GO)." NIH developed the GO grant program to...ng funds provided by the American Recovery and Rei...und projects that promise to have a significant im...
(Date:11/23/2009)... This release is available in German . , A...trument wouldn,t be a bad thing. It could help to ... to measure. However, it must do so constructively...l measurement with more than just imagination, phy...cs have formulated a theory of spatial perception ...
(Date:11/22/2009)... A team of pioneering South Korean scientists have...yday plastics through bioengineering, rather than ...is groundbreaking research, which may now allow fo...tics, is published in two papers in the journal B...al,s 50th anniversary. , Polymers are molecules...
Breaking Biology News(10 mins):NIGMS invests in scientific Grand Opportunities with Recovery Act funds 2NIGMS invests in scientific Grand Opportunities with Recovery Act funds 3Visual assistance for cosmic blind spots 2Visual assistance for cosmic blind spots 3Visual assistance for cosmic blind spots 4Bioengineers succeed in producing plastic without the use of fossil fuels 2PDX Rx com Works With Microsoft HealthVault to Make Prescription Data Available to Patients 48262 1PDX Rx com Works With Microsoft HealthVault to Make Prescription Data Available to Patients 48262 2PDX Rx com Works With Microsoft HealthVault to Make Prescription Data Available to Patients 48262 3The Physicians Organization of the University Medical Center at Princeton Chooses iMedicas EHR and Practice Management Solutions 48260 1The Physicians Organization of the University Medical Center at Princeton Chooses iMedicas EHR and Practice Management Solutions 48260 2The Physicians Organization of the University Medical Center at Princeton Chooses iMedicas EHR and Practice Management Solutions 48260 3Study Results Present Efficacy and Safety Findings from the PHIRST 1 Study of Patients with Pulmonary Arterial Hypertension Taking Tadalafil Tablets O 4575 1Study Results Present Efficacy and Safety Findings from the PHIRST 1 Study of Patients with Pulmonary Arterial Hypertension Taking Tadalafil Tablets O 4575 2Study Results Present Efficacy and Safety Findings from the PHIRST 1 Study of Patients with Pulmonary Arterial Hypertension Taking Tadalafil Tablets O 4575 3Study Results Present Efficacy and Safety Findings from the PHIRST 1 Study of Patients with Pulmonary Arterial Hypertension Taking Tadalafil Tablets O 4575 4Study Results Present Efficacy and Safety Findings from the PHIRST 1 Study of Patients with Pulmonary Arterial Hypertension Taking Tadalafil Tablets O 4575 5Study Results Present Efficacy and Safety Findings from the PHIRST 1 Study of Patients with Pulmonary Arterial Hypertension Taking Tadalafil Tablets O 4575 6
...lop a clearer picture of what makes some people st...esearchers who last year identified the first comm...entified a further twenty regions of the genome wh... 6cm. , The results, published together with two...ature Genetics, mean that scientists now know of d...
...(HHMI) researchers have found that rare mutations ...ion in the general population. , The scientists ha...t handling genes cause several rare diseases that ...cing DNA samples obtained from 3,125 people who ar... researchers identified new functional mutations i...
...m, controls many metabolic functions and is based ...r cycle that is important in determining sleeping ... biological processes in mammals. , The newly dis...tes in the hypothalamus, a region of the brain tha...onomic nervous system. But unlike the circadian rh...
Other Biology News:A tall story: New research adds to growing body of knowledge of genetics of height 2Rare genetic mutations protect against hypertension 2Rare genetic mutations protect against hypertension 3Rare genetic mutations protect against hypertension 4NYU dental professor discovers biological clock linking tooth growth to other metabolic processes 2
...00A can be upgraded to the GenePix Autoloader 4200...ans, analyzes, and saves results for up to 36 slid...omplete. Line-by-line autofocus ensures superior f...ro gives you complete flexibility to configure sca...
Dulbecco's Phosphate Buffered Saline (DPBS) from Sigma-Aldrich
...microarray data using Asuragens bioinformatics exp...ation to extensive data analysis using the most up...tion with the Gene Expression Profiling Service or...lization and basic statistical analysis including ...
Illumina Standard Data Analysis Report from Asuragen, Inc.
Biology Products: